%0 Journal Article %T Current PD-L1 immunohistochemistry for non-small cell lung cancer %A Scheel, Andreas H. %A Schäfer, Stephan C. %J Journal of Thoracic Disease %D 2018 %B 2018 %9 %! Current PD-L1 immunohistochemistry for non-small cell lung cancer %K %X Immunotherapy that targets PD-1 or PD-L1 by monoclonal antibodies has emerged as effective and safe new treatment of malignant tumours. It is most beneficial in highly immunogenic tumours, in particular in malignant melanoma (1) and in non-small cell lung cancer (NSCLC) (2). Immunohistochemistry (IHC) of PD-L1 protein may serve as predictive biomarker for both PD-1 and PD-L1 inhibitors. %U https://jtd.amegroups.org/article/view/19421 %V 10 %N 3 %P 1217-1219 %@ 2077-6624